NCT01742390

A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Si Tianmei · Academic / Other
• Sex: All
• Age: 12 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This trial designed to investigate the effect of switching to aripiprazole from risperidone or paliperidone on reverse prolactin level, and consequently improve sexual dysfunction in adult patients with schizophrenia spectrum disorders and bipolar spectrum disorders.

Conditions

• Sexual Dysfunction
• Hyperprolactinemia

Interventions

Type	Name	Description
DRUG	Aripiprazole	Plateau switch to aripiprazole (ARI) from risperidone (RIS) or paliperidone (PALI)
DRUG	risperidone or paliperidone

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-12-01
• Completion: 2014-06-01
• First posted: 2012-12-05
• Last updated: 2013-03-14

Locations

2 sites across 1 country: China